Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program
MORRONE, D., CHEN, C., DINSHAW, L., JIANG, W., KIM, Y. H., KIRCHHOF, P., KORETSUNE, Y., PECEN, Ladislav, REIMITZ, P. E., WANG, C. C., YAMASHITA, T., UNVERDORBEN, M., DE CATERINA, R. Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program. European Heart Journal. 2021, 42(Suppl. 1), 2980-2980. ISSN 0195-668X. E-ISSN 1522-9645 Dostupné z: doi:10.1093/eurheartj/ehab724.2980
